GENE ONLINE|News &
Opinion
Blog

Janssen Pharmaceutica
FDA Boxed Warning for CAR-T therapy, Affecting Bristol-Myers Squibb, Novartis, Janssen, Gilead Sciences
2024-01-24
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Janssen Drops Out of Prostate Cancer Clinical Trial Due to Lack of Patients
2022-11-01
Janssen Scores Another Multiple Myeloma FDA Approval with Tecvayli
2022-10-25
Study for Janssen Pharmaceuticals’ Severe Plaque Psoriasis Treatment Provides Optimization Insight
2022-09-08
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Dr. Reddy Stands as the First Indian Firm to Launch Cancer Drug in Chinese Market
2021-10-15
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
Janssen’s Long-acting Schizophrenia Drug Notches FDA Approval
2021-09-02
FDA Approves First Targeted Therapy for EGFR Lung Cancer with Exon 20 Mutations
2021-05-24
Janssen’s Multiple Sclerosis Drug Snags FDA Win after Besting Sanofi’s Blockbuster in Phase 3
2021-03-21
Insilico’s AI Pipeline for Drug Discovery To Grow with New Partnership
2020-11-11
Legend Biotech Closes Initial Public Offering Raising Big Money
2020-06-10
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
1 2
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top